Abstract:BACKGROUND: Cardiac chamber-selective transcriptional programs underpin the structural and functional differences between atrial and ventricular cardiomyocytes (aCMs and vCMs). The mechanisms responsible for these chamber-selective transcriptional programs remain largely undefined. METHODS: We nominated candidate chamber-selective enhancers (CSEs) by determining the genome-wide occupancy of 7 key cardiac transcription factors (GATA4, MEF2A, MEF2C, NKX2-5, SRF, TBX5, TEAD1) and transcriptional coactivator P300 in atria and ventricles. Candidate enhancers were tested using an adeno-associated virus-mediated massively parallel reporter assay. Chromatin features of CSEs were evaluated by performing assay of transposase accessible chromatin sequencing and acetylation of histone H3 at lysine 27-HiChIP on aCMs and vCMs. CSE sequence requirements were determined by systematic tiling mutagenesis of 29 CSEs at 5 bp resolution. Estrogen-related receptor (ERR) function in cardiomyocytes was evaluated by Cre-loxP-mediated inactivation of ERR alpha and ERR gamma in cardiomyocytes. RESULTS: We identified 134 066 and 97 506 regions reproducibly occupied by at least 1 transcription factor or P300, in atria or ventricles, respectively. Enhancer activities of 2639 regions bound by transcription factors or P300 were tested in aCMs and vCMs by adeno-associated virus-mediated massively parallel reporter assay. This identified 1092 active enhancers in aCMs or vCMs. Several overlapped loci associated with cardiovascular disease through genome-wide association studies, and 229 exhibited chamber-selective activity in aCMs or vCMs. Many CSEs exhibited differential chromatin accessibility between aCMs and vCMs, and CSEs were enriched for aCM- or vCM-selective acetylation of histone H3 at lysine 27-anchored loops. Tiling mutagenesis of 29 CSEs identified the binding motif of ERR alpha/gamma as important for ventricular enhancer activity. The requirement of ERR alpha/gamma to activate ventricular CSEs and promote vCM identity was confirmed by loss of the vCM gene profile in ERR alpha/gamma knockout vCMs. CONCLUSIONS: We identified 229 CSEs that could be useful research tools or direct therapeutic gene expression. We showed that chamber-selective multi-transcription factor, P300 occupancy, open chromatin, and chromatin looping are predictive features of CSEs. We found that ERR alpha/gamma are essential for maintenance of ventricular identity. Finally, our gene expression, epigenetic, 3-dimensional genome, and enhancer activity atlas provide key resources for future studies of chamber-selective gene regulation.

Landscape of Enhancer-Enhancer Cooperative Regulation During Human Cardiac Commitment

Insight into the regulatory mechanism of dynamic chromatin 3D interactions during cardiomyocyte differentiation in Human

P2570Synergistic Activation of the Cardiac Enhancer Landscape During Reprogramming

Spatiotemporal Gene Coexpression and Regulation in Mouse Cardiomyocytes of Early Cardiac Morphogenesis.

Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells.

Promoter interactome of human embryonic stem cell-derived cardiomyocytes connects GWAS regions to cardiac gene networks

A Reference Map of Murine Cardiac Transcription Factor Chromatin Occupancy Identifies Dynamic and Conserved Enhancers.

Co-Occupancy By Multiple Cardiac Transcription Factors Identifies Transcriptional Enhancers Active In Heart

Dynamic changes in P300 enhancers and enhancer-promoter contacts control mouse cardiomyocyte maturation

Pioneering function of Isl1 in the epigenetic control of cardiomyocyte cell fate.

Molecular Signatures and Networks of Cardiomyocyte Differentiation in Humans and Mice.

Novel enhancers conferring compensatory transcriptional regulation of Nkx2-5 in heart development

In Vivo Dissection of Chamber-Selective Enhancers Reveals Estrogen-Related Receptor as a Regulator of Ventricular Cardiomyocyte Identity

Functional Dissection of the Enhancer Repertoire in Human Embryonic Stem Cells

Dynamic Control of Enhancer Repertoires Drives Lineage and Stage-Specific Transcription During Hematopoiesis

Single-cell multi-modal integrative analyses highlight functional dynamic gene regulatory networks directing human cardiac development

The evolutionary ancient MEIS transcription factors actuate lineage-specific transcription to establish cardiac fate

Increased Enhancer—Promoter Interactions during Developmental Enhancer Activation in Mammals

A transcriptional enhancer regulates cardiac maturation

Genome-Wide Temporal Profiling of Transcriptome and Open Chromatin of Early Cardiomyocyte Differentiation Derived from Hipscs and Hescs

Single-cell reconstruction of differentiation trajectory reveals a critical role of ETS1 in human cardiac lineage commitment